Given the absence of predictive markers of AD, the identification of prognostic plasma markers is of the utmost importance, and it would be interesting to assess the prognostic value of plasma VCAN and ACAN for stratifying the risk of AD and rupture. This evidence concerns the gene VCAN and Alzheimer disease.